Whole-exome sequencing reveals novel candidate single nucleotide variations for preventing adverse effects of levonorgestrel implantation.
Pharmacogenomics
; 22(18): 1185-1199, 2021 12.
Article
in En
| MEDLINE
| ID: mdl-34783250
Aim: To identify novel genes associated with adverse effects of levonorgestrel (LNG) implants based on comparative whole-exome sequencing. Materials & methods: A cohort comprising 104 participants, including 52 controls and 52 women with LNG-related adverse effects, was recruited. Seven cases and eight controls were selected for whole-exome sequencing. We verified 13 single nucleotide variations (SNVs) related with integrin-mediated signaling pathway and cell proliferation using the MassARRAY platform. Results: Finally, we screened 49 cases and 52 controls for analyses. Two SNVs (rs7255721 and rs1042522) were located in ADAMTS10 and TP53, respectively, and significantly different between two groups. These two SNVs lead to changes in protein structure and physicochemical parameters. Conclusion: Here, we defined two pathogenic mutations related to adverse LNG effects.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Levonorgestrel
/
Polymorphism, Single Nucleotide
/
Drug-Related Side Effects and Adverse Reactions
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Pharmacogenomics
Journal subject:
FARMACOLOGIA
/
GENETICA MEDICA
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: